SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-21-007256
Filing Date
2021-03-26
Accepted
2021-03-26 08:40:40
Documents
3
Period of Report
2021-03-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A snbp20210325_8ka.htm 8-K/A 28113
2 EXHIBIT 99.1 ex_237103.htm EX-99.1 172560
3 logo.jpg GRAPHIC 9531
  Complete submission text file 0001437749-21-007256.txt   215288
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39468 | Film No.: 21774839
SIC: 2834 Pharmaceutical Preparations